Table of Contents
2019-2024 Global Chimeric Antigen Receptor Cell Therapy Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size 2014-2024
2.1.2 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region
2.2 Chimeric Antigen Receptor Cell Therapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 Chimeric Antigen Receptor Cell Therapy Market Size by Type
2.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (2014-2019)
2.4 Chimeric Antigen Receptor Cell Therapy Segment by Application
2.4.1 Acute Leukemia
2.4.2 Non-hodgkin's Lymphoma
2.4.3 Multiple Myeloma
2.4.4 Transplant Rejection
2.4.5 Other
2.5 Chimeric Antigen Receptor Cell Therapy Market Size by Application
2.5.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Application (2014-2019)
3 Global Chimeric Antigen Receptor Cell Therapy by Players
3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Players
3.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Players (2017-2019)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Players (2017-2019)
3.2 Global Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Chimeric Antigen Receptor Cell Therapy by Regions
4.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions
4.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size Growth
4.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size Growth
4.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth
4.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth
5 Americas
5.1 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Countries
5.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type
5.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Countries
6.2 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type
6.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Chimeric Antigen Receptor Cell Therapy by Countries
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy by Countries
8.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type
8.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Chimeric Antigen Receptor Cell Therapy Market Forecast
10.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2019-2024)
10.2 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions
10.2.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Chimeric Antigen Receptor Cell Therapy Forecast by Type
10.8 Global Chimeric Antigen Receptor Cell Therapy Forecast by Application
11 Key Players Analysis
11.1 Amgen Inc
11.1.1 Company Details
11.1.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Amgen Inc News
11.2 Autolus Therapeutics Plc
11.2.1 Company Details
11.2.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Autolus Therapeutics Plc News
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Company Details
11.3.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd News
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Company Details
11.4.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Bellicum Pharmaceuticals Inc News
11.5 Bristol-Myers Squibb Co
11.5.1 Company Details
11.5.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Bristol-Myers Squibb Co News
11.6 bluebird bio Inc
11.6.1 Company Details
11.6.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 bluebird bio Inc News
11.7 CARsgen Therapeutics Ltd
11.7.1 Company Details
11.7.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 CARsgen Therapeutics Ltd News
11.8 Celgene Corp
11.8.1 Company Details
11.8.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Celgene Corp News
11.9 Cell Medica Ltd
11.9.1 Company Details
11.9.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Cell Medica Ltd News
11.10 Cellular Biomedicine Group Inc
11.10.1 Company Details
11.10.2 Chimeric Antigen Receptor Cell Therapy Product Offered
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Cellular Biomedicine Group Inc News
11.11 Celularity Inc
11.12 Celyad SA
11.13 Daiichi Sankyo Co Ltd
11.14 Fosun Pharmaceutical AG
11.15 Gilead Sciences Inc
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.17 Hangzhou Converd Co Ltd
11.18 Hebei Senlang Biotechnology Inc Ltd
11.19 HRAIN Biotechnology Co Ltd
11.20 Juno Therapeutics Inc
11.21 Kite Pharma Inc
11.22 Nanjing Legend Biotech Co Ltd
11.23 NantKwest Inc
11.24 Nkarta Inc
11.25 Novartis AG
11.26 Ono Pharmaceutical Co Ltd
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.28 Sorrento Therapeutics Inc
11.29 Takara Bio Inc
12 Research Findings and Conclusion
